BRUKER CORP
Ticker: BRKRHealthcareMedical InstrumentsThe business
Bruker Corporation (NASDAQ: BRKR) is a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company's technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies. Bruker's products and solutions address the needs of customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. The company maintains major technical and manufacturing centers in Europe and North America with sales offices located throughout the world. More information is available at www.bruker.com.
Bruker operates through four reportable segments. The BSI BioSpin segment focuses on magnetic resonance spectroscopy, preclinical imaging, biopharma and applied solutions, services and lifecycle support, integrated data solutions, and laboratory automation. The BSI CALID segment comprises life sciences mass spectrometry, applied mass spectrometry, microbiology and infection diagnostics, and optics divisions. The BSI NANO segment includes X-ray instruments, nano surfaces and metrology, spatial biology, fluorescence microscopy, and cellular analysis. The BEST segment designs and manufactures superconducting materials and related products for medical, research, and industrial applications.
The company's customer base includes academic and government research facilities, pharmaceutical and biotechnology companies, contract research organizations, hospitals, clinical laboratories, food and beverage companies, environmental testing facilities, and industrial manufacturers. Bruker's sales approach combines direct sales forces across North America, Europe, China, Japan, and the Asia Pacific region with indirect channels including international distributors and independent sales representatives. The company's sales cycles vary significantly by product type, ranging from two weeks to six months for industrial products to more than two years for large, complex high-end contracts.
- Sector
- Healthcare
- Industry
- Medical Instruments
- HQ
- BILLERICA, MA
- FY end
- 12-31
- CIK
- 1109354
- SIC
- 3826
Ownership
Who holds BRUKER CORP — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| iShares Core S&P Mid-Cap ETF IJH · iShares Trust | 0.18% | $228.91M |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VTI · VANGUARD INDEX FUNDS | 0.01% | $203.41M |
| Strategic Advisers Fidelity U.S. Total Stock Fund FCTDX · Fidelity Rutland Square Trust II | 0.06% | $160.71M |
| VANGUARD SMALL-CAP INDEX FUND VB · VANGUARD INDEX FUNDS | 0.08% | $147.12M |
| Fidelity Series Large Cap Stock Fund FGLGX · Fidelity Hastings Street Trust | 0.49% | $141.93M |
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Go deeper in your own AI
15 years of statements, narrative and filings — queryable over MCP.
Professionals can also use the built-in AI chat (subscription + your own Anthropic key).
15 years of BRUKER CORP's financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free